Hormone treatment approved for breast cancer prevention
Anastrozole is now licensed to prevent breast cancer in postmenopausal women who are at increased risk of the disease.

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.